Difference between revisions of "STBT5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
 
(6 intermediate revisions by 2 users not shown)
Line 6: Line 6:
  
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br />
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br />
 +
__TOC__
 
{| class="wikitable" style="margin:auto"
 
{| class="wikitable" style="margin:auto"
 
|+<big>WHO Classification of Soft Tissue and Bone Tumours (5th edition) Content</big>
 
|+<big>WHO Classification of Soft Tissue and Bone Tumours (5th edition) Content</big>
Line 16: Line 17:
 
!'''Date of Last Editor Review'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
!'''Notes'''
−
!
 
−
!
 
−
!
 
−
!
 
−
!
 
 
|-
 
|-
−
|CHAPTER 2 (SOFT TISSUE TUMOURS)
 
 
|
 
|
−
----
+
==== CHAPTER 2 (SOFT TISSUE TUMOURS) ====
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
 
|
 
|
 
----
 
----
Line 54: Line 41:
 
|[[STBT5:Lipoma|Lipoma]]
 
|[[STBT5:Lipoma|Lipoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 70: Line 52:
 
|[[STBT5:Lipomatosis|Lipomatosis]]
 
|[[STBT5:Lipomatosis|Lipomatosis]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 86: Line 63:
 
|[[STBT5:Lipomatosis_of_nerve|Lipomatosis of nerve]]
 
|[[STBT5:Lipomatosis_of_nerve|Lipomatosis of nerve]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 102: Line 74:
 
|[[STBT5:Lipoblastoma_and_lipoblastomatosis|Lipoblastoma and lipoblastomatosis]]
 
|[[STBT5:Lipoblastoma_and_lipoblastomatosis|Lipoblastoma and lipoblastomatosis]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 123: Line 90:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Myolipoma_of_soft_tissue|Myolipoma of soft tissue]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 132: Line 105:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Myolipoma_of_soft_tissue|Myolipoma of soft tissue]]
+
|[[STBT5:Chondroid_lipoma|Chondroid lipoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 142: Line 115:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Spindle_cell_lipoma_and_pleomorphic_lipoma|Spindle cell lipoma and pleomorphic lipoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Chondroid_lipoma|Chondroid lipoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 155: Line 126:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Hibernoma|Hibernoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 164: Line 138:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Spindle_cell_lipoma_and_pleomorphic_lipoma|Spindle cell lipoma and pleomorphic lipoma]]
+
|[[STBT5:Atypical_spindle_cell_/_pleomorphic_lipomatous_tumour|Atypical spindle cell / pleomorphic lipomatous tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 174: Line 148:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Hibernoma|Hibernoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 187: Line 159:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Dedifferentiated_liposarcoma|Dedifferentiated liposarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 196: Line 171:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Atypical_spindle_cell_/_pleomorphic_lipomatous_tumour|Atypical spindle cell / pleomorphic lipomatous tumour]]
+
|[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 206: Line 181:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Pleomorphic_liposarcoma_|Pleomorphic liposarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 219: Line 192:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Myxoid_pleomorphic_liposarcoma|Myxoid pleomorphic liposarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 228: Line 204:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Dedifferentiated_liposarcoma|Dedifferentiated liposarcoma]]
+
|[[STBT5:Nodular_fasciitis|Nodular fasciitis]]
 
|Disease
 
|Disease
 
|
 
|
Line 238: Line 214:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 251: Line 225:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 260: Line 237:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Pleomorphic_liposarcoma_|Pleomorphic liposarcoma]]
+
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
 
|Disease
 
|Disease
 
|
 
|
Line 270: Line 247:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Elastofibroma|Elastofibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 275: Line 255:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Myxoid_pleomorphic_liposarcoma|Myxoid pleomorphic liposarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 288: Line 268:
 
|
 
|
 
|
 
|
 +
|
 +
|-
 +
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Nodular_fasciitis|Nodular fasciitis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 299: Line 280:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 308: Line 292:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]
+
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 318: Line 302:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 331: Line 313:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 340: Line 325:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
+
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 350: Line 335:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Elastofibroma|Elastofibroma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 363: Line 346:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 372: Line 358:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
+
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 382: Line 368:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 395: Line 379:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 404: Line 391:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
+
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 414: Line 401:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 427: Line 412:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 436: Line 424:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
+
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 443: Line 431:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 452: Line 446:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
+
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 462: Line 456:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 475: Line 467:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 484: Line 479:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
+
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 
|Disease
 
|Disease
 +
|Shashi Shetty and Reba Daniel (resident)
 +
|2/21/2024
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|Katherine Geiersbach
 
|
 
|
−
|
+
|Template added 2/21/2024
−
|
+
|-
 +
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 500: Line 501:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
+
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 510: Line 511:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 523: Line 522:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 532: Line 534:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
+
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 542: Line 544:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 555: Line 555:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 564: Line 567:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
+
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 574: Line 577:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 579: Line 585:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 592: Line 598:
 
|
 
|
 
|
 
|
 +
|
 +
|-
 +
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 603: Line 610:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 612: Line 622:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
+
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
 
|Disease
 
|Disease
 
|
 
|
Line 622: Line 632:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 635: Line 643:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 644: Line 655:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
+
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 654: Line 665:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 659: Line 673:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 673: Line 687:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
 +
|Disease
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 683: Line 697:
 
|
 
|
 
|
 
|
 +
|
 +
|-
 +
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 692: Line 710:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
+
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
 
|Disease
 
|Disease
−
|Shashi Shetty and Reba Daniel (resident)
 
−
|2/21/2024
 
 
|
 
|
−
|PENDING
 
 
|
 
|
−
|Katherine Geiersbach
 
 
|
 
|
−
|Template added 2/21/2024
 
 
|
 
|
 
|
 
|
Line 708: Line 721:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
+
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 718: Line 731:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 731: Line 742:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 740: Line 754:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
+
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 747: Line 761:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 756: Line 776:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
+
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 766: Line 786:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Angiosarcoma|Angiosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 779: Line 797:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Glomus_tumour|Glomus tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 788: Line 809:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
+
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 798: Line 819:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 811: Line 830:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Leiomyoma|Leiomyoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 820: Line 842:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
+
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 830: Line 852:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 843: Line 863:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 852: Line 875:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
+
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 862: Line 885:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 875: Line 896:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 884: Line 908:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
+
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 900: Line 919:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
+
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 910: Line 929:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 923: Line 940:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 932: Line 952:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
+
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 942: Line 962:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 955: Line 973:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Schwannoma|Schwannoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 964: Line 985:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
+
|[[STBT5:Neurofibroma|Neurofibroma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 980: Line 996:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
+
|[[STBT5:Perineurioma|Perineurioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 990: Line 1,006:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,003: Line 1,017:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,012: Line 1,029:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
+
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,022: Line 1,039:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,035: Line 1,050:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,044: Line 1,062:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
+
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 1,060: Line 1,073:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
+
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,070: Line 1,083:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,083: Line 1,094:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,092: Line 1,106:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
+
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,102: Line 1,116:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,115: Line 1,127:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,124: Line 1,139:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
+
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 1,140: Line 1,150:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Angiosarcoma|Angiosarcoma]]
+
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,147: Line 1,157:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,156: Line 1,172:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Glomus_tumour|Glomus tumour]]
+
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,166: Line 1,182:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,179: Line 1,193:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,188: Line 1,205:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
+
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
 
|Disease
 
|Disease
 +
|James Solomon, MD, PhD
 +
|2/20/2022
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|Alanna Church
 
|
 
|
 
|
 
|
−
|
+
|-
 +
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,204: Line 1,227:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Leiomyoma|Leiomyoma]]
+
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,214: Line 1,237:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,227: Line 1,248:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,236: Line 1,260:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
+
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,243: Line 1,267:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,252: Line 1,282:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
+
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,262: Line 1,292:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:PEComa|PEComa]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,275: Line 1,303:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,284: Line 1,315:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
+
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,294: Line 1,325:
 
|
 
|
 
|
 
|
 +
|-
 
|
 
|
 +
==== CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE) ====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
+
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
 
|Disease
 
|Disease
 +
|Sadeem Qdaisat
 +
|10/1/23
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|Working with Eric McGinnis
 
|
 
|
−
|
+
|2021 template added
−
|
+
|-
 +
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,316: Line 1,369:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
+
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
 
|Disease
 
|Disease
 +
|Ganesh Pandurang, MD
 +
|2/28/24
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|Katherine Geiersbach
 
|
 
|
 
|
 
|
−
|
+
|-
 +
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,332: Line 1,391:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
 
−
|Disease
 
 
|
 
|
 +
==== CHAPTER 4 (BONE TUMOURS) ====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,355: Line 1,422:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,364: Line 1,434:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
+
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,374: Line 1,444:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Enchondroma|Enchondroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,379: Line 1,452:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Osteochondroma|Osteochondroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,392: Line 1,465:
 
|
 
|
 
|
 
|
 +
|
 +
|-
 +
|[[STBT5:Chondroblastoma|Chondroblastoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,403: Line 1,477:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,412: Line 1,489:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Schwannoma|Schwannoma]]
+
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,422: Line 1,499:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Neurofibroma|Neurofibroma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,435: Line 1,510:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,444: Line 1,522:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Perineurioma|Perineurioma]]
+
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,454: Line 1,532:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,467: Line 1,543:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,476: Line 1,555:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
+
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,486: Line 1,565:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,499: Line 1,576:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,508: Line 1,588:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
+
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,518: Line 1,598:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Osteoma|Osteoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,531: Line 1,609:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,540: Line 1,621:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
+
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,550: Line 1,631:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,563: Line 1,642:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Osteosarcoma|Osteosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,572: Line 1,654:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
+
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,582: Line 1,664:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,595: Line 1,675:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,604: Line 1,687:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
+
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,614: Line 1,697:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,619: Line 1,705:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,632: Line 1,718:
 
|
 
|
 
|
 
|
 +
|
 +
|-
 +
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,643: Line 1,730:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,652: Line 1,742:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
+
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,662: Line 1,752:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,675: Line 1,763:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,684: Line 1,775:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
+
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,694: Line 1,785:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,707: Line 1,796:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,716: Line 1,808:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
+
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,726: Line 1,818:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,739: Line 1,829:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,748: Line 1,841:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
+
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
 
|Disease
 
|Disease
−
|James Solomon, MD, PhD
 
−
|2/20/2022
 
−
|
 
−
|PENDING
 
 
|
 
|
−
|Alanna Church
 
 
|
 
|
 
|
 
|
Line 1,764: Line 1,852:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
+
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,774: Line 1,862:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,787: Line 1,873:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,796: Line 1,885:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
+
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,806: Line 1,895:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,819: Line 1,906:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,828: Line 1,918:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
+
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,838: Line 1,928:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,851: Line 1,939:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Bone_metastases|Bone metastases]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,860: Line 1,951:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
+
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,870: Line 1,961:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:PEComa|PEComa]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,883: Line 1,972:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,892: Line 1,984:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
+
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 1,908: Line 1,995:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
+
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,918: Line 2,005:
 
|
 
|
 
|
 
|
 +
|-
 
|
 
|
 +
==== CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE) ====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
 
−
|Disease
 
−
|Sadeem Qdaisat
 
−
|10/1/23
 
−
|
 
−
|PENDING
 
−
|
 
−
|Working with Eric McGinnis
 
−
|
 
−
|2021 template added
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Enchondroma|Enchondroma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Osteochondroma|Osteochondroma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Chondroblastoma|Chondroblastoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Osteoma|Osteoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Osteosarcoma|Osteosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Bone_metastases|Bone metastases]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Enchondromatosis|Enchondromatosis]]
 
−
|Disease
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[STBT5:Enchondromatosis|Enchondromatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 2,918: Line 2,040:
 
|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 
|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 
|Disease
 
|Disease
−
|
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|-
 
|-
 
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]]
 
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,950: Line 2,062:
 
|[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]]
 
|[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,966: Line 2,073:
 
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 
|Disease
 
|Disease
−
|
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|-
 
|-
 
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]
 
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,998: Line 2,095:
 
|[[STBT5:Werner_syndrome|Werner syndrome]]
 
|[[STBT5:Werner_syndrome|Werner syndrome]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|

Latest revision as of 13:47, 10 September 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Soft Tissue and Bone Tumours (5th edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (SOFT TISSUE TUMOURS)
Lipoma Disease
Lipomatosis Disease
Lipomatosis of nerve Disease
Lipoblastoma and lipoblastomatosis Disease
Angiolipoma Disease
Myolipoma of soft tissue Disease
Chondroid lipoma Disease
Spindle cell lipoma and pleomorphic lipoma Disease
Hibernoma Disease
Atypical spindle cell / pleomorphic lipomatous tumour Disease
Atypical lipomatous tumour / well-differentiated liposarcoma Disease
Dedifferentiated liposarcoma Disease
Myxoid liposarcoma Disease
Pleomorphic liposarcoma Disease
Myxoid pleomorphic liposarcoma Disease
Nodular fasciitis Disease
Proliferative fasciitis and proliferative myositis Disease
Myositis ossificans and fibro-osseous pseudotumour of digits Disease
Ischaemic fasciitis Disease
Elastofibroma Disease
Fibrous hamartoma of infancy Disease
Fibromatosis colli Disease
Juvenile hyaline fibromatosis Disease
Inclusion body fibromatosis Disease
Fibroma of tendon sheath Disease
Desmoplastic fibroblastoma Disease
Myofibroblastoma Disease
Calcifying aponeurotic fibroma Disease
EWSR1-SMAD3-positive fibroblastic tumour (emerging) Disease
Angiomyofibroblastoma Disease
Cellular angiofibroma Disease
Angiofibroma of soft tissue Disease
Nuchal-type fibroma Disease
Acral fibromyxoma Disease
Gardner fibroma Disease
Palmar fibromatosis and plantar fibromatosis Disease
Desmoid fibromatosis Disease
Lipofibromatosis Disease
Giant cell fibroblastoma Disease
Dermatofibrosarcoma protuberans Disease
Solitary fibrous tumour Disease Shashi Shetty and Reba Daniel (resident) 2/21/2024 PENDING Katherine Geiersbach Template added 2/21/2024
Inflammatory myofibroblastic tumour Disease
Low-grade myofibroblastic sarcoma Disease
Superficial CD34-positive fibroblastic tumour Disease
Myxoinflammatory fibroblastic sarcoma Disease
Infantile fibrosarcoma Disease
Adult fibrosarcoma Disease
Myxofibrosarcoma Disease
Low-grade fibromyxoid sarcoma Disease
Sclerosing epithelioid fibrosarcoma Disease
Tenosynovial giant cell tumour Disease
Deep fibrous histiocytoma Disease
Plexiform fibrohistiocytic tumour Disease
Giant cell tumour of soft tissue Disease
Synovial haemangioma Disease
Intramuscular angioma Disease
Arteriovenous malformation/haemangioma Disease
Venous haemangioma Disease
Anastomosing haemangioma Disease
Epithelioid haemangioma Disease
Lymphangioma and lymphangiomatosis Disease
Tufted angioma and kaposiform haemangioendothelioma Disease
Retiform haemangioendothelioma Disease
Papillary intralymphatic angioendothelioma Disease
Composite haemangioendothelioma Disease
Kaposi sarcoma Disease
Pseudomyogenic haemangioendothelioma Disease
Epithelioid haemangioendothelioma Disease
Angiosarcoma Disease
Glomus tumour Disease
Myopericytoma, including myofibroma Disease
Angioleiomyoma Disease
Leiomyoma Disease
EBV-associated smooth muscle tumour Disease
Inflammatory leiomyosarcoma Disease
Leiomyosarcoma Disease
Rhabdomyoma Disease
Embryonal rhabdomyosarcoma Disease
Alveolar rhabdomyosarcoma Disease
Pleomorphic rhabdomyosarcoma Disease
Spindle cell / sclerosing rhabdomyosarcoma Disease
Ectomesenchymoma Disease
Gastrointestinal stromal tumour Disease
Soft tissue chondroma Disease
Extraskeletal osteosarcoma Disease
Schwannoma Disease
Neurofibroma Disease
Perineurioma Disease
Granular cell tumour Disease
Dermal nerve sheath myxoma Disease
Solitary circumscribed neuroma Disease
Ectopic meningioma and meningothelial hamartoma Disease
Benign triton tumour / neuromuscular choristoma Disease
Hybrid nerve sheath tumour Disease
Malignant peripheral nerve sheath tumour Disease
Malignant melanotic nerve sheath tumour Disease
Intramuscular myxoma Disease
Juxta-articular myxoma Disease
Deep (aggressive) angiomyxoma Disease
Atypical fibroxanthoma Disease
Angiomatoid fibrous histiocytoma Disease
Ossifying fibromyxoid tumour Disease
Myoepithelioma, myoepithelial carcinoma, and mixed tumour Disease
Pleomorphic hyalinizing angiectatic tumour of soft parts Disease
Haemosiderotic fibrolipomatous tumour Disease
Phosphaturic mesenchymal tumour Disease
NTRK-rearranged spindle cell neoplasm (emerging) Disease James Solomon, MD, PhD 2/20/2022 PENDING Alanna Church
Synovial sarcoma Disease
Epithelioid sarcoma Disease
Alveolar soft part sarcoma Disease
Clear cell sarcoma of soft tissue Disease
Extraskeletal myxoid chondrosarcoma Disease
Desmoplastic small round cell tumour Disease
Extrarenal rhabdoid tumour Disease
PEComa Disease
Intimal sarcoma Disease
Undifferentiated sarcoma Disease

CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)
Ewing sarcoma Disease Sadeem Qdaisat 10/1/23 PENDING Working with Eric McGinnis 2021 template added
Round cell sarcoma with EWSR1-non-ETS fusions Disease
CIC-rearranged sarcoma Disease Ganesh Pandurang, MD 2/28/24 PENDING Katherine Geiersbach
Sarcoma with BCOR genetic alterations Disease

CHAPTER 4 (BONE TUMOURS)
Subungual exostosis Disease
Bizarre parosteal osteochondromatous proliferation Disease
Periosteal chondroma Disease
Enchondroma Disease
Osteochondroma Disease
Chondroblastoma Disease
Chondromyxoid fibroma Disease
Osteochondromyxoma Disease
Synovial chondromatosis Disease
Central atypical cartilaginous tumour / chondrosarcoma, grade 1 Disease
Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1 Disease
Central chondrosarcoma, grades 2 and 3 Disease
Secondary peripheral chondrosarcoma, grades 2 and 3 Disease
Periosteal chondrosarcoma Disease
Clear cell chondrosarcoma Disease
Mesenchymal chondrosarcoma Disease
Dedifferentiated chondrosarcoma Disease
Osteoma Disease
Osteoid osteoma Disease
Osteoblastoma Disease
Low-grade central osteosarcoma Disease
Osteosarcoma Disease
Parosteal osteosarcoma Disease
Periosteal osteosarcoma Disease
High-grade surface osteosarcoma Disease
Secondary osteosarcoma Disease
Desmoplastic fibroma of bone Disease
Fibrosarcoma of bone Disease
Haemangioma of bone Disease
Epithelioid haemangioma of bone Disease
Epithelioid haemangioendothelioma of bone Disease
Angiosarcoma of bone Disease
Aneurysmal bone cyst Disease
Giant cell tumour of bone Disease
Non-ossifying fibroma Disease
Benign notochordal cell tumour Disease
Conventional chordoma Disease
Dedifferentiated chordoma Disease
Poorly differentiated chordoma Disease
Chondromesenchymal hamartoma of chest wall Disease
Osteofibrous dysplasia Disease
Adamantinoma of long bones Disease
Simple bone cyst Disease
Fibrocartilaginous mesenchymoma Disease
Fibrous dysplasia Disease
Lipoma and hibernoma of bone Disease
Leiomyosarcoma of bone Disease
Undifferentiated pleomorphic sarcoma Disease
Bone metastases Disease
Solitary plasmacytoma of bone Disease
Primary non-Hodgkin lymphoma of bone Disease
Langerhans cell histiocytosis Disease
Erdheim-Chester disease Disease
Rosai-Dorfman disease Disease

CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)
Enchondromatosis Disease
Li-Fraumeni syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
McCune-Albright syndrome Disease
Multiple osteochondromas Disease
Neurofibromatosis type 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Rothmund-Thomson syndrome Disease
Werner syndrome Disease


Retrieved from "https://ccga.io/index.php?title=STBT5:Volunteer_Assignments_and_Opportunities&oldid=15409"